KDM5B and non-small cell lung carcinoma: Recent studies confirmed that hypoxia could mediate the up-regulation of tissue protein deacetylase LSD1 and PLU-1, and promote the resistance to gefitinib in NSCLC with EGFR activating mutation [28].